GCP
BRLI

GSA Capital Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

GSA Capital Partners’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-17,911
Closed -$457K – 1980
2013
Q4 		$457K Buy
17,911
+8,204
+85% +$253K 0.04% 916
2013
Q3 		$290K Sell
9,707
-9,167
-49% -$255K 0.02% 1166
2013
Q2 		$543K Buy
+18,874
New +$520K 0.06% 496

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GSA Capital Partners's BRLI Position: Q1 2014 in Review

GSA Capital Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 17,911 shares — an estimated $457K sold.

GSA Capital Partners first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $543K in Q2 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • GSA Capital Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • GSA Capital Partners sold 17,911 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $457K.
  • GSA Capital Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • GSA Capital Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $543K in Q2 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on GSA Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.